Dokuyucu Recep, Gokce Hasan, Sahan Mustafa, Sefil Fatih, Tas Zeynel Abidin, Tutuk Okan, Ozturk Atakan, Tumer Cemil, Cevik Cengiz
Department of Medical Physiology, School of Medicine, Mustafa Kemal University Hatay, Turkey.
Department of Pathology, School of Medicine, Mustafa Kemal University Hatay, Turkey.
Int J Clin Exp Med. 2015 Feb 15;8(2):2674-8. eCollection 2015.
The object of the study is to experimentally investigate the possible systemic side effects of Oxymetazoline including its nasal spray which has been in use for a long time both by the physicians and patients. There is no study in the literature to address the damages of oxymetazoline on the end organ.
The study conducted on 2 groups of rat. Group 1 (n = 8): Control; and Group 2 (n = 8): Oxymetazoline. During 4 week, the control group was applied with 2 drops of saline water on each nasal cavity 3 times a day and the other group was applied with 2 drops of oxymetazoline HCl 3 times a day. At the end of experiment, samples from mandible, parotid and tails of the rats were taken in 10% formalin for histopathological investigations.
In histopathological experiments, when compared with the control group, the oxymetazoline group showed significant increase in many of the histopathological parameters (ischemic changes: P = 0.0001; congestion: P = 0.0006; arterial thrombosis: P = Ns; PNL accumulations: P = 0.001; necrosis: P = 0.0001; and ulceration: P = 0.014). The results of histopathologic tests on the samples taken from mandible and parotid gland, in comparison with the control group, showed no significant increase (focal inflammation: P = Ns; and lymphocyte aggregation: P = Ns).
Due to the damage that the long-term use of nasal spray including oxymetazoline, it may cause injury on the end organ, which we revealed in our histopathological experiments. We believe that it's essential for the physicians to provide information on the side effects of the medicine to their patients who use for a long term.
本研究旨在通过实验探究去氧肾上腺素可能产生的全身副作用,包括其鼻喷雾剂,该药物长期以来一直被医生和患者使用。文献中尚无关于去氧肾上腺素对终末器官损害的研究。
对两组大鼠进行研究。第1组(n = 8):对照组;第2组(n = 8):去氧肾上腺素组。在4周内,对照组每天在每个鼻腔滴注2滴生理盐水,共3次,另一组每天在每个鼻腔滴注2滴盐酸去氧肾上腺素,共3次。实验结束时,取大鼠的下颌骨、腮腺和尾巴样本,用10%福尔马林固定,进行组织病理学检查。
在组织病理学实验中,与对照组相比,去氧肾上腺素组的许多组织病理学参数显著增加(缺血性改变:P = 0.0001;充血:P = 0.0006;动脉血栓形成:P =无显著差异;中性粒细胞聚集:P = 0.001;坏死:P = 0.0001;溃疡形成:P = 0.014)。与对照组相比,取自下颌骨和腮腺的样本的组织病理学检查结果显示无显著增加(局灶性炎症:P =无显著差异;淋巴细胞聚集:P =无显著差异)。
由于长期使用包括去氧肾上腺素在内的鼻喷雾剂会造成损害,我们在组织病理学实验中发现其可能会对终末器官造成损伤。我们认为,医生向长期使用该药物的患者提供药物副作用信息至关重要。